Market revenue in 2023 | USD 131.6 million |
Market revenue in 2030 | USD 224.5 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.6% in 2023. Horizon Databook has segmented the UK real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
One of the key factors contributing to market growth in the UK is the country’s large geriatric population. According to the UK government, the number of people within the age group of 60 years to 64 years. The increasing geriatric population is likely to fuel market growth, as the aging population is at greater risk of chronic illnesses, which increases the rate of hospitalization in this group.
According to a report published in the NCBI, individuals aged over 50 years are more likely to suffer from chronic diseases such as intracranial stenosis and idiopathic intracranial stenosis, as with age, blood vessels deteriorate.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account